Multiple drug

Multiple drug Reactions 1680, p235 - 2 Dec 2017 causality score was 1 (possibly treatment related). CAse 8: A 61-year-old man, who was diagnosed with HCV- infection and cirrhosis received treatment with sofosbuvir and ribavirin. After 1.9 weeks of the treatment, he developed Various toxicities: 16 case reports * hyperbilirubinaemia. Later, he was hospitalised due to In a observational cohort study, 16 patients (5 women and – portosystemic encephalopathy. Her hyperbilirubinaemia 11 men) aged 40 79 years were described, who developed improved after ribavirin dosage reduction and portosystemic various toxicities during treatment with sofosbuvir, simeprevir, encephalopathy improved with unspecified medications. The ribavirin or peginterferon-alfa [dosages and routes not stated]. total duration of treatment was 24 weeks. The causality score Out of these 16 patients, one patient died of multiple organ was 3 (likely treatment related). failure. Case 9: A 67-year-old man, who was diagnosed with HCV- Case 1: A 78-year-old woman, who was diagnosed with infection received treatment with sofosbuvir and ribavirin. HCV-infection, lymphoma and cirrhosis received treatment After 8 weeks of the treatment, he developed anaemia and with sofosbuvir and ribavirin. After 2.9 weeks of the treatment, required hospitalised and blood transfusion. Later, he she developed variceal bleeding and was http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Multiple drug

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Loading next page...
 
/lp/springer_journal/multiple-drug-hIFKkAS6pI
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39166-3
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p235 - 2 Dec 2017 causality score was 1 (possibly treatment related). CAse 8: A 61-year-old man, who was diagnosed with HCV- infection and cirrhosis received treatment with sofosbuvir and ribavirin. After 1.9 weeks of the treatment, he developed Various toxicities: 16 case reports * hyperbilirubinaemia. Later, he was hospitalised due to In a observational cohort study, 16 patients (5 women and – portosystemic encephalopathy. Her hyperbilirubinaemia 11 men) aged 40 79 years were described, who developed improved after ribavirin dosage reduction and portosystemic various toxicities during treatment with sofosbuvir, simeprevir, encephalopathy improved with unspecified medications. The ribavirin or peginterferon-alfa [dosages and routes not stated]. total duration of treatment was 24 weeks. The causality score Out of these 16 patients, one patient died of multiple organ was 3 (likely treatment related). failure. Case 9: A 67-year-old man, who was diagnosed with HCV- Case 1: A 78-year-old woman, who was diagnosed with infection received treatment with sofosbuvir and ribavirin. HCV-infection, lymphoma and cirrhosis received treatment After 8 weeks of the treatment, he developed anaemia and with sofosbuvir and ribavirin. After 2.9 weeks of the treatment, required hospitalised and blood transfusion. Later, he she developed variceal bleeding and was

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off